Warnings and Contraindications Special precautions should be taken by specific populations when using Rybelsus, Semaglutide
In a statement, Novo Nordisk, maker of the GLP-1 drug semaglutide, noted, For Wegovy specifically, animal studies suggest there may be risks to the fetus, and weight loss during pregnancy offers no benefit and may cause harm
The mistakes that cause premature degradation are nearly universal, they happen because they seem harmless, because old habits persist, or because nobody explained why these specific actions matter at the molecular level
HEALTH RISK REDUCTION Lower blood pressure, cholesterol, and decrease cardiovascular disease risk
Most notably, it slows down gastric motility, meaning food stays in the stomach longer
Semaglutide slows digestion, which can leave more food and acid in the stomach for longer